Physician profile
Michael Freitas
NPI 1093033953
$15,074.95
in general payments reported to CMS, 2019-2025
55 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,135 · 2020: $1,423 · 2021: $2,972 · 2022: $4,244 · 2023: $1,709 · 2024: $1,486 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,300.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $3,691.67 | 2021-2023 | |
| Novo Nordisk INC | $1,907.67 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,456.03 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,293.00 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $1,265.85 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $1,002.51 | 2021-2025 | |
| Astellas Pharma US INC | $501.32 | 2019-2022 | |
| Glaxosmithkline, LLC. | $335.80 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $250.53 | 2022-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $236.67 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $200.64 | 2019-2023 | |
| Pfizer INC. | $188.08 | 2019-2025 | |
| Pacira Therapeutics, INC. | $178.54 | 2019-2020 | |
| Edwards Lifesciences Corporation | $176.45 | 2020-2025 | Sapien 3 Ultra Resilia |
| Mylan Specialty L.P. | $155.81 | 2019-2024 | Yupelri |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Freitas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.